Literature DB >> 15353305

Immunopathogensis of HTLV-I associated neurologic disease: molecular, histopathologic, and immunologic approaches.

Norihiro Takenouchi1, Karen Yao, Steven Jacobson.   

Abstract

Human T-cell lymphotropic virus type I (HTLV-I) infection is associated with a variety of human diseases including HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP), a chronic progressive inflammatory neurological disease. An important risk factor for the development of HAM/TSP is thought to be a high HTLV-I proviral load. Histopathological studies have demonstrated the presence of HTLV-I virus in the affected areas of spinal cords from HAM/TSP patients. Furthermore, T-cell infiltrations have been shown in spinal cord lesions. The precise mechanism for disease development is still unknown. Virus-host immune interactions are considered to play an important role in disease pathogenesis. This review focuses on current molecular, histopathological, and immunological approaches to understand the immunopathogenesis of HAM/TSP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15353305     DOI: 10.2741/1414

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  11 in total

1.  Human T-lymphotropic virus type I or II (HTLV-I/II) associated with recurrent longitudinally extensive transverse myelitis (LETM): two case reports.

Authors:  Silvia R Delgado; William A Sheremata; Andrew D Brown; Micheline McCarthy
Journal:  J Neurovirol       Date:  2010-05       Impact factor: 2.643

2.  The NK cell as a new player in the pathogenesis of HTLV-I associated neurologic disease.

Authors:  Steven Jacobson
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

3.  Brain volume measurements in patients with human T-cell lymphotropic virus-1-associated tropical spastic paraparesis.

Authors:  C Griffith; F Bagnato; S Gupta; A Calabrese; U Oh; A Chiu; J M Ohayon; M J McAuliffe; T A Tasciyan; S Jacobson
Journal:  J Neurovirol       Date:  2006-10       Impact factor: 2.643

Review 4.  HERVs in neuropathogenesis.

Authors:  Tove Christensen
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-27       Impact factor: 4.147

5.  Proinflammatory cytokine gene induction by human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 Tax in primary human glial cells.

Authors:  Prabal Banerjee; Rosemary Rochford; J Antel; G Canute; Stephen Wrzesinski; Michelle Sieburg; Gerold Feuer
Journal:  J Virol       Date:  2006-11-22       Impact factor: 5.103

Review 6.  HTLV-1 Yin and Yang: Rex and p30 master regulators of viral mRNA trafficking.

Authors:  Hicham H Baydoun; Marcia Bellon; Christophe Nicot
Journal:  AIDS Rev       Date:  2008 Oct-Dec       Impact factor: 2.500

7.  Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability.

Authors:  Cynthia A Pise-Masison; Michael Radonovich; Kathleen Dohoney; John C Morris; Deirdre O'Mahony; Min-Jung Lee; Jane Trepel; Thomas A Waldmann; John E Janik; John N Brady
Journal:  Blood       Date:  2009-01-08       Impact factor: 22.113

Review 8.  HTLV-1 and innate immunity.

Authors:  Chloé Journo; Renaud Mahieux
Journal:  Viruses       Date:  2011-08-08       Impact factor: 5.048

Review 9.  Role of resident CNS cell populations in HTLV-1-associated neuroinflammatory disease.

Authors:  Veronique Lepoutre; Pooja Jain; Kevin Quann; Brian Wigdahl; Zafar K Khan
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

10.  HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT).

Authors:  Keiko Yasuma; Jun-ichirou Yasunaga; Keiko Takemoto; Kenji Sugata; Yuichi Mitobe; Norihiro Takenouchi; Masanori Nakagawa; Yutaka Suzuki; Masao Matsuoka
Journal:  PLoS Pathog       Date:  2016-01-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.